PRESIDENT & CEO of Tandem Diabetes Care Inc (30-Year Financial, Insider Trades) John F Sheridan (insider trades) sold 30,000 shares of TNDM on 02/21/2020 at an average price of $87.86 a share. The total sale was $2.6 million.
Tandem Diabetes Care Inc is a provider of medical care devices in the United States. Its products aid in the delivery of insulin and getting accurate readings through its software application. Tandem Diabetes Care Inc has a market cap of $5.13 billion; its shares were traded at around $86.79 with and P/S ratio of 15.32. Tandem Diabetes Care Inc had annual average EBITDA growth of 51.70% over the past five years. GuruFocus has detected 1 severe warning sign with Tandem Diabetes Care Inc. .
CEO Recent Trades:
- PRESIDENT & CEO John F Sheridan sold 30,000 shares of TNDM stock on 02/21/2020 at the average price of $87.86. The price of the stock has decreased by 1.22% since.
Directors and Officers Recent Trades:
- EVP, Chief Legal & Compliance David B Berger sold 16,000 shares of TNDM stock on 02/13/2020 at the average price of $82.67. The price of the stock has increased by 4.98% since.
- EVP & CHIEF FINANCIAL OFFICER Leigh Vosseller sold 10,000 shares of TNDM stock on 02/11/2020 at the average price of $80.04. The price of the stock has increased by 8.43% since.
- EVP, Chief Legal & Compliance David B Berger sold 2,000 shares of TNDM stock on 02/03/2020 at the average price of $75.46. The price of the stock has increased by 15.01% since.
- EVP & CHIEF COMMERCIAL OFFICER Brian B Hansen sold 50,000 shares of TNDM stock on 01/30/2020 at the average price of $75.8. The price of the stock has increased by 14.5% since.
- EVP & CHIEF FINANCIAL OFFICER Leigh Vosseller sold 10,000 shares of TNDM stock on 01/29/2020 at the average price of $75.93. The price of the stock has increased by 14.3% since.
For the complete insider trading history of TNDM, click here
.
